These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30625040)

  • 41. The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI.
    Hellgren R; Saracco A; Strand F; Eriksson M; Sundbom A; Hall P; Dickman PW
    Acta Radiol; 2020 Dec; 61(12):1600-1607. PubMed ID: 32216451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
    J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Background parenchymal enhancement over exam time in patients with and without breast cancer.
    Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
    J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Foci on breast magnetic resonance imaging in high-risk women: cancer or not?
    Clauser P; Cassano E; De Nicolò A; Rotili A; Bonanni B; Bazzocchi M; Zuiani C
    Radiol Med; 2016 Aug; 121(8):611-7. PubMed ID: 27169908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
    Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
    Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
    J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI Texture Analysis of Background Parenchymal Enhancement of the Breast.
    Amano Y; Woo J; Amano M; Yanagisawa F; Yamamoto H; Tani M
    Biomed Res Int; 2017; 2017():4845909. PubMed ID: 28812015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Choi JS; Ko ES; Ko EY; Han BK; Nam SJ
    Medicine (Baltimore); 2016 Mar; 95(9):e3000. PubMed ID: 26945421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
    JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging.
    Yoon HJ; Kim Y; Lee JE; Kim BS
    Eur Radiol; 2015 Jan; 25(1):32-40. PubMed ID: 25216768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Background parenchymal enhancement in breast magnetic resonance imaging: A review of current evidences and future trends.
    Rella R; Bufi E; Belli P; Contegiacomo A; Giuliani M; Rosignuolo M; Rinaldi P; Manfredi R
    Diagn Interv Imaging; 2018 Dec; 99(12):815-826. PubMed ID: 30249463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
    Onishi N; Li W; Newitt DC; Harnish RJ; Strand F; Nguyen AA; Arasu VA; Gibbs J; Jones EF; Wilmes LJ; Kornak J; Joe BN; Price ER; Ojeda-Fournier H; Eghtedari M; Zamora KW; Woodard S; Umphrey HR; Nelson MT; Church AL; Bolan PJ; Kuritza T; Ward K; Morley K; Wolverton D; Fountain K; Lopez Paniagua D; Hardesty L; Brandt KR; McDonald ES; Rosen M; Kontos D; Abe H; Sheth D; Crane E; Dillis C; Sheth P; Hovanessian-Larsen L; Bang DH; Porter B; Oh KY; Jafarian N; Tudorica LA; Niell B; Drukteinis J; Newell MS; Giurescu ME; Berman E; Lehman CD; Partridge SC; Fitzpatrick KA; Borders MH; Yang WT; Dogan B; Goudreau SH; Chenevert T; Yau C; DeMichele A; Berry DA; Esserman LJ; Hylton NM
    Radiology; 2021 Nov; 301(2):295-308. PubMed ID: 34427465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Magn Reson Imaging; 2016 Feb; 34(2):173-6. PubMed ID: 26597834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
    Kerlikowske K; Su YR; Sprague BL; Tosteson ANA; Buist DSM; Onega T; Henderson LM; Alsheik N; Bissell MCS; O'Meara ES; Lee CI; Miglioretti DL
    JAMA; 2022 Jun; 327(22):2220-2230. PubMed ID: 35699706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.
    Price ER; Brooks JD; Watson EJ; Brennan SB; Comen EA; Morris EA
    Eur Radiol; 2014 Jan; 24(1):162-8. PubMed ID: 23982290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer.
    Albert M; Schnabel F; Chun J; Schwartz S; Lee J; Klautau Leite AP; Moy L
    Clin Imaging; 2015; 39(6):987-92. PubMed ID: 26351036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
    AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
    [No Abstract]   [Full Text] [Related]  

  • 59. Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.
    Preibsch H; Wanner L; Bahrs SD; Wietek BM; Siegmann-Luz KC; Oberlecher E; Hahn M; Staebler A; Nikolaou K; Wiesinger B
    Eur Radiol; 2016 Jun; 26(6):1590-6. PubMed ID: 26382845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible Breast Cancer Risk Related to Background Parenchymal Enhancement at Breast MRI: A Meta-Analysis Study.
    Zhang H; Guo L; Tao W; Zhang J; Zhu Y; Abdelrahim MEA; Bai G
    Nutr Cancer; 2021; 73(8):1371-1377. PubMed ID: 32700575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.